IG
AMED

ING Group’s Amedisys AMED Stock Holding History

ING Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-98,000
Closed -$9.64M – 512
2025
Q2 		$9.64M Buy
98,000
+36,000
+58% +$3.41M 0.06% 175
2025
Q1 		$5.74M Hold
62,000
– – 0.04% 222
2024
Q4 		$5.63M Hold
62,000
– – 0.04% 265
2024
Q3 		$5.98M Sell
62,000
-160,300
-72% -$15.6M 0.03% 270
2024
Q2 		$20.4M Buy
222,300
+45,500
+26% +$4.22M 0.12% 128
2024
Q1 		$16.3M Sell
176,800
-13,000
-7% -$1.22M 0.11% 160
2023
Q4 		$18M Hold
189,800
– – 0.14% 144
2023
Q3 		$17.7M Buy
189,800
+136,700
+257% +$12.6M 0.16% 125
2023
Q2 		$4.86M Buy
+53,100
New +$4.36M 0.04% 262
2019
Q2 		– Sell
-4,464
Closed -$550K – 750
2019
Q1 		$550K Buy
+4,464
New +$560K 0.01% 430

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

ING Group's AMED Position: Q3 2025 in Review

ING Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 98,000 shares — an estimated $9.64M sold.

ING Group first reported a position in AMED in Q1 2019 and held it in 10 quarters. The position peaked at $20.4M in Q2 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • ING Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • ING Group sold 98,000 Amedisys shares in Q3 2025, an estimated $9.64M.
  • ING Group first reported a position in Amedisys in Q1 2019 and held it in 10 quarters.
  • ING Group's Amedisys position peaked at $20.4M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on ING Group's 13F filing for Q3 2025, filed 6 Nov 2025.